Inhibition of tnf-α-mediated nf-kb transcriptional activity by dammarane-type ginsenosides from steamed flower buds of panax ginseng in hepg2 and sk-hep1 cells

Biomolecules and Therapeutics

Volumn 22, Issue 1, 2014, Pages 55-61

  Cho, Kyoungwon ^a   Song, Seok Bean ^a   Tung, Nguyen Huu ^a   Kim, Kyoon Eon ^a   Kim, Young Ho ^a  

^a Chungnam National University   (South Korea)

Author keywords

Hepatocyte derived cells; Nf kb inhibitory activity; Panax ginseng flower buds; Tumor necrosis factor

Indexed keywords

6' ACETYL GINSENOSIDE RG 1; APIGENIN; CXCL1 CHEMOKINE; DAMMARANE DERIVATIVE; GINSENOSIDE; GINSENOSIDE F 1; GINSENOSIDE F 4; GINSENOSIDE MB; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 2; GINSENOSIDE RG 6; GINSENOSIDE RH 4; GINSENOSIDE RK 3; GINSENOSIDE RK 6; GINSENOSIDE RS 4; GINSENOSIDE SF; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; NITRIC OXIDE SYNTHASE; PSEUDOGINSENOSIDE RC 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VINAGINSENOSIDE R 4;

ARTICLE; BUD; CELL STRAIN; CELL STRAIN HEPG2; CELL STRAIN SK HEP1; CONTROLLED STUDY; CXCL1 GENE; DRUG MECHANISM; DRUG STRUCTURE; GENE; GINSENG; HUMAN; HUMAN CELL; ICAM1 GENE; IL8 GENE; INFLAMMATION; INOS GENE; LIVER INJURY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

EID: 84893074871     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2013.096     Document Type: Article

References (33)

1. Baek, N. I., Kim, D. S., Lee, Y. H., Park, J. D., Lee, C. B. and Kim, S. I. (1996) Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng. Planta Med. 62, 86-87.
2. Berasain, C., Castillo, J., Perugorria, M. J., Latasa, M. U., Prieto, J. and Avila, M. A. (2009) Inflammation and liver cancer: new molecular links. Ann. N. Y. Acad. Sci. 1155, 206-221.
3. Christensen, L. P. (2009) Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv. Food Nutr. Res. 55, 1-99.
4. Elsharkawy, A. M. and Mann, D. A. (2007) Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46, 590-597.
5. Ernst, E. (2010) Panax ginseng: An Overview of the Clinical Evidence. J. Ginseng Res. 34, 259-263.
6. Farinati, F., Piciocchi, M., Lavezzo, E., Bortolami, M. and Cardin, R. (2010) Oxidative stress and inducible nitric oxide synthase induction in carcinogenesis. Dig. Dis. 28, 579-584.
7. Funakoshi-Tago, M., Nakamura, K., Tago, K., Mashino, T. and Kasahara, T. (2011) Anti-inflammatory activity of structurally related flavonoids, apigenin, luteolin and fisetin. Int. Immunopharmacol. 11, 1150-1159.
8. Gasparini, C. and Feldmann, M. (2012) NF-κB as a target for modulating inflammatory responses. Curr. Pharm. Des. 18, 5735-5745
9. Hofseth, L. J. and Wargovich, M. J. (2007) Inflammation, cancer, and targets of ginseng. J. Nutr. 137, 183S-185S.
10. Holt, A. P., Salmon, M., Buckley, C. D. and Adams, D. H. (2008) Immune interactions in hepatic fibrosis. Clin. Liver Dis. 12, 861-882.
11. Kawanishi, S., Hiraku, Y., Pinlaor, S. and Ma, N. (2006) Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 387, 365-372.
12. Kim, S. E., Lee, Y. H., Park, J. H. and Lee, S. K. (1999) Ginsenoside- Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. Eur. J. Cancer 35, 507-511.
13. Lee, I. A., Hyam, S. R., Jang, S. E., Han, M. J. and Kim, D. H. (2012) Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages. J. Agric. Food Chem. 60, 9595-9602
14. Lee, J. G., Baek, S. H., Lee, Y. Y., Park, S. Y. and Park, J. H. (2011) Anti- complementary ginsenosides isolated from processed ginseng. Biol. Pharm. Bull. 34, 898-900.
15. Lentsch, A. B. and Ward, P. A. (2000) The NFkappaBb/IkappaB system in acute inflammation. Arch. Immunol. Ther. Exp. (Warsz) 48, 59-63.
16. Li, Q. and Verma, I. M. (2002) NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
17. Liu, G. Y., Li, X. W., Wang, N. B., Zhou, H. Y., Wei, W., Gui, M. Y., Yang, B. and Jin, Y. R. (2010) Three new dammarane-type triterpene saponins from the leaves of Panax ginseng C.A. Meyer. J. Asian Nat. Prod. Res. 12, 865-873.
18. Luqman, S. and Pezzuto, J. M. (2010) NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother. Res. 24, 949-963.
19. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancerrelated inflammation. Nature 454, 436-444.
20. Nam, N. H. (2006) Naturally occurring NF-kappaB inhibitors. Mini Rev. Med. Chem. 6, 945-951.
21. Park, T. Y., Park, M. H., Shin, W. C., Rhee, M. H., Seo, D. W., Cho, J. Y. and Kim, H. M. (2008) Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol. Pharm. Bull. 31, 1802-1805.
22. Song, S. B., Tung, N. H., Quang, T. H., Ngan, N. T., Kim, K. E. and Kim, Y. H. (2012) Inhibition of TNF-α-mediated NF-κB transcriptional activity in HepG2 cells by dammarane-type saponins from Panax ginseng leaves. J. Ginseng Res. 36, 146-152.
23. Sun, J., Sun, G., Meng, X., Wang, H., Wang, M., Qin, M., Ma, B., Luo, Y., Yu, Y., Chen, R., Ai, Q. and Sun, X. (2013) Ginsenoside RK3_prevents hypoxia-reoxygenation induced apoptosis in H9c2 cardiomyocytes via AKT and MAPK pathway. Evid. Based Complement Alternat. Med. 2013, 690190.
24. Toh, D. F., Patel, D. N., Chan, E. C., Teo, A., Neo, S. Y. and Koh, H. L. (2011) Anti-proliferative effects of raw and steamed extracts of Panax notoginseng and its ginsenoside constituents on human liver cancer cells. Chin. Med. 6, 4.
25. Tung, N. H., Song, G. Y., Park, Y. J. and Kim, Y. H. (2009) Two new dammarane-type saponins from the leaves of Panax ginseng. Chem. Pharm. Bull. (Tokyo) 57, 1412-1414.
26. Tung, N. H., Song, G. Y., Minh, C. V., Kiem, P. V., Jin, L. G., Boo, H. J., Kang, H. K. and Kim, Y. H. (2010a) Steamed ginseng-leaf components enhance cytotoxic effects on human leukemia HL-60 cells. Chem. Pharm. Bull. (Tokyo) 58, 1111-1115.
27. Tung, N. H., Cho, K., Kim, J. A., Song, G. Y. and Kim, Y. H. (2010b) Dammarane-type glycosides from the steamed flower-buds of Panax ginseng. Bull. Korean Chem. Soc. 31, 1381-1384.
28. Tung, N. H., Song, G. Y., Kim, J. A., Hyun, J. H., Kang, H. K. and Kim, Y. H. (2010c) Dammarane-type saponins from the flower buds of Panax ginseng and their effects on human leukemia Cells. Bioorg. Med. Chem. Lett. 20, 309-314.
29. Tung, N. H., Song, G. Y., Nhiem, N. X., Ding, Y., Tai, B.H., Jin, L. G., Lim, C. M., Hyun, J. W., Park, C. J., Kang, H. K. and Kim, Y. H. (2010d) Dammarane-type saponins from the flower buds of Panax ginseng and their intracellular radical scavenging capacity. J. Agric. Food Chem. 58, 868-874.
30. Tung, N. H., Quang, T. H., Son, J. H., Koo, J. E., Hong, H. J., Koh, Y. S., Song, G. Y. and Kim, Y. H. (2011) Inhibitory effect of ginsenosides from steamed ginseng-leaves and flowers on the LPSstimulated IL-12 production in bone marrow-derived dendritic cells. Arch. Pharm. Res. 34, 681-685.
31. Vuksan, V., Sievenpipper, J., Jovanovski, E. and Jenkins, A. L. (2010) Current clinical evidence for Korean red ginseng in management of diabetes and vascular disease: a Toronto's ginseng clinical testing program. J. Ginseng Res. 34, 264-273.
32. Wang, H., Peng, D. and Xie, J. (2009) Ginseng leaf-stem: bioactive constituents and pharmacological functions. Chin. Med. 4, 20.
33. Wang, L., Zhang, Y., Wang, Z., Li, S., Min, G., Wang, L., Chen, J., Cheng, J. and Wu, Y. (2012) Inhibitory effect of ginsenoside-Rd on carrageenan-induced inflammation in rats. Can. J. Physiol. Pharmacol. 90, 229-236.